6月3日 - ** 药物研发公司Cocrystal Pharma（COCP.O）的股价在盘前交易中上涨5.1%，至1.10美元
** 该公司任命萨皮尔斯坦（James Sapirstein）为首席执行官，即日起生效
** 公司还计划任命萨皮尔斯坦为董事会董事
** 萨皮尔斯坦将接替此前担任联合首席执行官的李（Sam Lee）和马丁（Jim Martin）
** 李将继续担任总裁并转任首席科学官，马丁将继续担任首席财务官
** 截至上一交易日收盘，该股今年以来累计下跌37.5%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.